Current and future perspectives of mRNA technology : vimarsa

New research reports on the current and future perspectives on messenger ribonucleic acid technology, the platform on which the first successful COVID-19 vaccine was based.

Related Keywords

China , United States , Zhenjiang , Jiangsu , , Pfizer , Current Status , Future Perspectives , Image Credit , Jiangsu Province , Coronavirus Disease Covid 19 , Drugs , Antibodies , Dancer , Fell , Chip , Coronavirus , Covid 19 , Cytoplasm , Na , Rna Polymerase , Nzyme , Gene , Immunity , Manufacturing , Medicine , Microfluidics , Microrna , Anoparticle , Pandemic , Olymerase , Reclinical , Protein , Eagents , Espiratory , Ibonucleic Acid , Cars , Ars Cov 2 , Evere Acute Respiratory , Evere Acute Respiratory Syndrome , Dirna , Yndrome , Ranscription , Vaccine , Virus ,